Arvinas at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

Arvinas takes part in 2 sessions at TPD Summit 2026 in Boston. Its sessions look at what the first approval of a targeted protein degrader means for the field, and at translational and clinical progress for degraders in neurology and immuno-oncology.

OrganizationTPD Summit 2026 Attendance
Arvinas
New Haven, CT
arvinas.com
Biotech
Biotech developing PROTAC protein degraders for cancer and neurological diseases.
Talk
Tue Oct 27
8:30am
Degradation Delivered – What the First TPD Approval Means for the Future of the Field
Plenary
Translational & clinical developmentInvestment, partnering & strategy
Talk
Wed Oct 28
12:30pm
The Expanding Frontier of Targeted Protein Degradation: Translational & Clinical Advances in Neurology & Immuno-Oncology
Track C: Translational & Clinical Development

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Arvinas

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction